Alaunos Therapeutics, Inc. Common Stock

TCRT XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

4.7M

Short interest (Jul 15)

0.5%

Net Short (Jul 27 ): -0.1%

Borrow Fee

1.50%

↓ 16.1%

Available Shares

40K

↓ 45.7%

Price Chart

Company Overview

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001107421

Asset Type: CS

Market Data

Market Cap: $4,737,763

Employees: 1

Status: Active

Short Interest

Current Borrow Fee 1.50%

Range: 1.50% - 2.17%

Available Shares 40K

Range: 30K - 45K

Recent Changes

Fee Change: ↓ 34.5%

Available Change: ↑ 7.1%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime